3rd Quarter - Report
WINNING STRATEGIES WASHINGTON for KALEO
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Pharmaceutical drug development including epinephrine for anaphylaxis
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARL CHIDLOW | — |
| MOLLY MCDONNELL | LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance |
| MICHAEL A MEROLA | Deputy CoS, Sen. Torricelli |
| DONNA MULLINS | CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa |
| CHARLA PENN | LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd |
| CHELSEY PENROD HICKMAN | CoS, Rep. Kay Granger; LA Sen. Larry Craig |
| ROBERT ZUCKER | LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg |
Health Issues HCR
Reducing opioid overdose deaths; S.771 Improving Access to Affordable Prescription Drugs Act, S.469 Affordable and Safe Prescription Drug Importation Act; monitoring policies and regulations related to the President's declaration of the opioid crisis as a public health emergency under the Public Health Service Act; S.3120 Helping to End Addiction and Lessen (HEAL) Substance Use Disorder Act of 2018
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARL CHIDLOW | n/a |
| MOLLY MCDONNELL | LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance |
| MICHAEL A MEROLA | Deputy CoS, Sen. Torricelli |
| DONNA MULLINS | CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa |
| CHARLA PENN | LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd |
| CHELSEY PENROD HICKMAN | CoS, Rep. Kay Granger; LA Sen. Larry Craig |
| ROBERT ZUCKER | LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.